Zanidatamab,Tislelizumab,Trastuzumab
zymeworks,beigene,novartis
we re committed to research in #gastriccancer care. today at #wcgic2022 we presented a poster reviewing our global phase 3 study, herizon-gea-01, for locally advanced, unresectable, or metastatic #her2-positive gastroesophageal adenocarcinoma (gea). 
We’re on a mission to bring patients home to their loved ones, disease free.